Abstract

Background: It has been reported that type 2 diabetes (T2DM) is associated with olfactory identification (OI) impairments and cognitive decline. However, the relationship between OI impairments and cognitive decline is largely unknown in T2DM patients.Methods: Sixty-eight T2DM patients and 68 healthy controls underwent 3D-T1 MRI scans, olfactory and cognitive assessments. The cortical thickness of olfaction-related brain regions, olfactory and cognitive scores were compared between groups. Correlation analyses were carried out among cognition, olfaction, and cortical thickness of olfaction-related brain regions.Results: First, the cognitive and olfactory test scores of T2DM patients were lower than healthy subjects. Second, higher olfactory scores were associated with increased cortical thickness in the left parahippocampal gyrus and bilateral insula in T2DM. Third, higher olfactory scores were associated with higher cognitive performance in T2DM. Fourth, some cognitive performances were related to cortical thickness in the left parahippocampal gyrus and left insula in T2DM.Conclusion: These findings indicated that olfactory dysfunction may be useful for future applications that attempt to predict cognitive decline or develop tailored therapies in T2DM patients.

Highlights

  • Diabetes is a chronic metabolic disorder, which is characterized by hyperglycemia

  • After false discovery rate (FDR) correction, we found significant positive correlations between Chinese smell identification test (CSIT)-olfactory identification (OI) scores and cortical thickness in the left parahippocampal gyrus (r = 0.340, P = 0.030), left insula (r = 0.303, P = 0.040) and right insula (r = 0.328, P = 0.030) in T2DM groups

  • We examined the alterations of cognitive function, cortical thickness of olfaction-related regions, and olfactory test scores in T2DM, and the relationships among them in T2DM and healthy controls

Read more

Summary

Introduction

Diabetes is a chronic metabolic disorder, which is characterized by hyperglycemia. It was estimated that 463 million people had diabetes in 2019, accounting for 9.3% of the global adult population (20–79 years old). This number is expected to increase to 578 million (10.2%) by 2030 and 700 million (10.9%) by 2045 (Saeedi et al, 2019). Previous studies have shown that chronic hyperglycemia can cause cognitive dysfunction (Cao et al, 2020). It has been reported that type 2 diabetes (T2DM) is associated with olfactory identification (OI) impairments and cognitive decline. The relationship between OI impairments and cognitive decline is largely unknown in T2DM patients

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.